{"id":"NCT01076452","sponsor":"US Department of Veterans Affairs","briefTitle":"Phase II Subthalamic Nucleus (STN) vs. Globus Pallidus (GPi) Trial","officialTitle":"CSP #468 Phase II - A Comparison of Best Medical Therapy and Deep Brain Stimulation of Subthalamic Nucleus and Globus Pallidus for the Treatment of Parkinson's Disease, Phase II","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2002-04","primaryCompletion":"2008-10","completion":"2009-04","firstPosted":"2010-02-26","resultsPosted":"2014-01-15","lastUpdate":"2014-07-14"},"enrollment":299,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Parkinson's Disease"],"interventions":[{"type":"DEVICE","name":"Bilateral Deep Brain Stimulation","otherNames":[]}],"arms":[{"label":"STN","type":"ACTIVE_COMPARATOR"},{"label":"GPi","type":"ACTIVE_COMPARATOR"}],"summary":"The goal of the second phase of the study is to determine if simultaneous bilateral subthalamic nucleus stimulation or simultaneous bilateral globus pallidus stimulation is more effective in reducing symptoms of Parkinson's Disease.","primaryOutcome":{"measure":"The Change From Baseline in the UPDRS-III Score at 24 Months With Deep-brain Stimulation and Without Medication.","timeFrame":"Baseline and 24 months","effectByArm":[{"arm":"STN (Subthalamic Nucleus)","deltaMin":-12.9,"sd":null},{"arm":"GPi (Globus Pallidus)","deltaMin":-13.1,"sd":null}],"pValues":[]},"eligibility":{"minAge":"22 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":9},"locations":{"siteCount":14,"countries":["United States"]},"refs":{"pmids":["19126811","20519680","22722632","23667214","25185211"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":83,"n":147},"commonTop":["Fall","Depression","Speech Disorder","Freezing Phenomenon","Gait Disturbance"]}}